Handling & storage: Store lyophilized powder at -20C
WATCH | WHO recommends GLP-1 therapies for obesity: Health Canada has also listed known risks associated with the use of genuine GLP-1 products, including severe gastrointestinal problems, pancreatitis, worsening kidney injury and low blood sugar, particularly if combined with other medications
However, the journey to weight loss can be more complex than anticipated
Sublingual semaglutide suspension is available in two strengths, each supplied in a 30 mL vial: 1mg/mL 2mg/mL Begin with a daily sublingual dose of 1 mg for 2-3 weeks, then gradually increase up to 1.5 mg daily, as needed
Ensure you are consuming adequate protein (0.8-1 gram per pound of body weight) to support muscle preservation, even when your appetite is suppressed